...
首页> 外文期刊>Methods: A Companion to Methods in Enzymology >Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level
【24h】

Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level

机译:微大RNA,长期非编码RNA和信使RNA之间的共表达分析,了解遗传水平的糖尿病肾疾病的发病机制和进展

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? Co-expression analysis among miR, lncRNAs, and mRNAs. ? Seamlessly integrating wet-lab experiments and computational-statistical analysis. ? Identified hsa-miR-223-3p as a candidate novel biomarker in DKD disease process. Abstract Diabetic kidney disease (DKD) is a serious disease that presents a major health problem worldwide. There is a desperate need to explore novel biomarkers to further facilitate the early diagnosis and effective treatment in DKD patients, thus preventing them from developing end-stage renal disease (ESRD). However, most regulation mechanisms at the genetic level in DKD still remain unclear. In this paper, we describe our innovative methodologies that integrate biological, computational, and statistical approaches to investigate important roles performed by regulations among microRNAs (miRs), long non-coding RNAs (lncRNAs), and messenger RNAs (mRNAs) in DKD. We conducted fully transparent, rigorously designed experiments. Our robust and reproducible results identified hsa-miR-223-3p as a candidate novel biomarker performing important roles in DKD disease process.
机译:强调 ? MIR,LNCRNA和MRNA之间的共表达分析。还无缝集成湿式实验室实验和计算统计分析。还将HSA-MIR-223-3P鉴定为DKD疾病过程中的候选新型生物标志物。摘要糖尿病肾病(DKD)是一种严重的疾病,呈现全球主要的健康问题。绝望需要探索新的生物标志物,以进一步促进DKD患者的早期诊断和有效治疗,从而防止它们发展末期肾病(ESRD)。然而,DKD遗传水平的大多数调节机制仍然尚不清楚。在本文中,我们描述了我们的创新方法,即整合生物,计算和统计方法来调查Micrornas(MIRS),长期非编码RNAS(LNCRNA)和DKD的信使RNA(MRNA)中的规定执行的重要角色。我们进行了完全透明,严格设计的实验。我们的稳健和可重复的结果确定了HSA-MIR-223-3P作为候选新型生物标志物在DKD疾病过程中表现重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号